Business Wire

Shark Tank-fame World’s Fastest Cooking Device On2Cook Secures Seed Funding Over 2 Million USD, Valuation Stands at 100 Crore


Inventor and Entrepreneur Sanandan (Sandy) Sudhir, who created quite some ripples in Shark Tank with the world’s fastest cooking device, has declared that his startup On2Cook India Pvt Ltd has secured seed funding of over 2 Million USD. The funding round was led by angel investor Dr Mayur Desai, who infused the first tranche of Rs 16 crore for 16% equity, reaffirming the startup’s valuation at 12.5 Million USD. The round also saw the participation of NRI investor Nirbhay Gandhi. On2Cook is currently making an appearance at GulfHost 2022 at World Trade Centre in Dubai.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

(L-R) Sanandan Sudhir, CEO & Founder On2Cook, Investor Shaival Desai from Desai family office (Photo: Business Wire)

“On2Cook works on the combination cooking technology with induction or flame acting on the food from outside and microwaves from inside. Engineered to disrupt the food industry, the product is designed to help both domestic as well as commercial kitchens save up to 70% on time and 50% on energy. Additionally, the food cooked retains water-soluble nutrients while preserving colour, texture and consistency. After being granted patents across India, US and UK, our invention stands to create a new product category in the kitchen space,” said On2Cook India Founder and CEO Sanandan Sudhir. He added that the brand is in talks with other strategic investors to raise another INR 3 crore as part of the round.

Echoing the sentiments, Shaival Desai from the Desai family office added, “There hasn't been a technological shift in the cooking appliances space in the post-industrial world for decades, if not centuries. On2Cook brings cooking into the 21st century. We are happy to join forces with Sanandan in his tryst to usher in a landmark transition in an industry, and even in the lifestyle of everyone.”

On2Cook has won several prestigious awards globally such as iF Design award, British Invention Show - Diamond Award for best International Invention and was the most celebrated Invention at CES, Las Vegas 2022. The device has been tested with more than 100 chefs and culinary experts across the globe. It can be used to cook everything from french fries, chicken to a cake with the softest base. Alongside ensuring faster and better quality food at a much economical price point, On2Cook makes cooking a seamless affair with app connectivity and eventually making the cognitive load negligible.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Sanandan (Sandy) Sudhir
On2Cook India Pvt Ltd.

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Enosium Life Science, a New Integrated Scientific Services Group for Biopharma Companies in Europe5.3.2024 12:00:00 EET | Press release

Dr Antoine Amer, supported by Otium Capital, announced the creation of Enosium Life Science, a group poised to redefine services in the healthcare market by acquiring and combining best-in-class life science experts in Europe. This press release features multimedia. View the full release here: Enosium Life Science aims to be a key advisory and scientific services provider for pharmaceuticals, biotech and medtech firms from clinical development to commercialisation. Antoine Amer brings 20+ years of global pharmaceutical leadership experience in launching and growing healthcare innovations. A Multi-Specialist European Group Dedicated to Life Sciences Enosium Life Science combines local knowledge, scientific expertise, entrepreneurial agility, and international standards to address critical challenges facing pharmaceutical companies. Enosium Life Science will implement a targeted acquisition strategy, focusing on service providers

Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer5.3.2024 11:02:00 EET | Press release

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, today announced successful completion of Good Manufacturing Practice (“GMP”) manufacturing of MOv18 IgE, Epsilogen’s lead IgE antibody drug candidate. This included process development and cGMP manufacturing of this complex molecule for clinical supply in less than ten months at Lonza’s Slough (UK) site. IgE antibodies represent powerful alternatives to more commonly used IgG antibodies. They bring exciting opportunities for oncology thanks to their strong potency, long tissue half-life, and the ability to target tumour cells expressing very low antigen levels. Current research and monitoring indicate that this is the first time GMP manufacturing of a therapeutic IgE antibody has been completed at scale. Epsilogen intends to use this new material for its upcoming Phase Ib study in p

Manhattan Unveils First Unified Commerce Benchmark for Specialty Retail in Europe5.3.2024 11:00:00 EET | Press release

Manhattan Associates Inc. (NASDAQ: MANH) today announced the findings of the industry's first real-world analysis of Unified Commerce in specialty retail in Europe conducted in partnership with Google Cloud and Zebra Technologies. The Unified Commerce Benchmark for Specialty Retail, conducted by Incisiv via actual shopping transactions, assessed three retail verticals (apparel and footwear, home and DIY, and luxury), and five countries (France, Germany, Italy, UK, and the Netherlands). The Unified Commerce Benchmark for Specialty Retail in Europe conducted by Incisiv, assessed 50 retailers, analysing 290+ customer experience capabilities in four categories including: search and discovery; cart and checkout; promising and fulfilment and service and support. Based on data from actual purchases, returns and customer journeys across digital and physical channels, the benchmarking reveals common attributes of successful retailers and opportunities for retailers to improve customer value and

Fujirebio Europe Expands Its Portfolio With Introduction of the Innovative PreCursor-M AnoGYN assay (RUO) for Methylation Testing in Anal Specimens5.3.2024 09:00:00 EET | Press release

Fujirebio Europe and Self-screen B.V. today announced an expansion of their commercial collaboration with the distribution of the PreCursor-M AnoGYN methylation-specific molecular assay from Self-screen B.V. The test is intended for the detection of promoter hypermethylation of the genes ASCL1 and ZNF582 and is used to test the methylations status of anal specimens for research use only (RUO). It complements Fujirebio's HPV-associated molecular test portfolio. “The Human Papilloma Virus (HPV) test panel of Fujirebio Europe continues to grow with effective and accurate testing solutions, and we are pleased to add this new RUO methylation-based assay to our molecular testing toolbox,” says Christiaan De Wilde, CEO at Fujirebio Europe “With its unmatched accuracy and reliability, this innovative PreCursor-M AnoGYN assay represents a significant advancement for research studies in the field of anal cancer prevention. We wanted our customers to have access to this valuable research tool as

HCLTech Launches AI Force to Accelerate Time-to-Value in Software Development and Engineering Lifecycle5.3.2024 07:52:00 EET | Press release

HCLTech, a leading global technology company, today announced the launch of HCLTech AI Force, an innovative GenAI platform that accelerates time-to-value by transforming the software development and engineering lifecycle, delivering greater productivity, improved quality and faster release timelines. The patented GenAI platform is built on Azure OpenAI and can be integrated with Microsoft GitHub Copilot, but is system agnostic. It offers a highly customizable suite of GenAI-based solutions that inject intelligence into every aspect of software development and engineering workflows to improve efficiency and developer experience. “We take great pride in spearheading the art of possible in AI and are thrilled to unveil this exciting innovation," said Vijay Guntur, President of Engineering and R&D Services, HCLTech. "This platform is a true game-changer and some of our pilots with clients in the technology and financial services industries have delivered extremely encouraging outcomes." Pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye